

Siren Biotechnology Virtual Closing Celebration + Live Q&A 🎉
​Join us for a special moment as we celebrate the close of Siren Biotechnology’s community investment round!
​Over the past few months, more than 1,300 investors have joined us to support the world’s first AAV universal gene therapy for cancer. Now, with our community round officially wrapping next week, we’re coming together to reflect, connect, and share what lies ahead.
​This virtual event is open to:
✅ Current investors
✅ Anyone curious about investing
✅ Supporters who believe in bold science and a better future for cancer care
​What to expect:
• A look behind the scenes with the Siren team
• Live Q&A - bring your questions!
• What’s next: FDA submission and human trials in 2026
• A virtual toast to YOU - our incredible community
​This is your last chance to get your questions answered before the round closes. If you’ve been thinking about investing (or know someone who is), don’t miss this.
​Let’s close strong — together. 💫